Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
In the world of mathematics, there are certain formulas that act as essential tools for problem-solving. Among these, the quadratic formula holds a special place for its ability to solve equations tha
By Dr. Eleanor Vance, Regulatory Affairs Editor
The fight against melanoma, the deadliest form of skin cancer, has taken a revolutionary step forward with the introduction of a personalised vaccine now in clinical trials in Britain. This groundbrea
By Tom Okafor, Clinical Trials Correspondent
A new antibiotic compound known as zosurabalpin shows great promise in early studies against carbapenem-resistant Acinetobacter baumannii (CRAB), a dangerous superbug that causes severe infections and
By James Whitfield, Manufacturing & Supply Chain Writer
The pharmaceutical industry stands at the crossroads of human health and technological advancement. Imagine it as a high-stakes chessboard. The game has been around for a long time, but suddenly, the
By Priya Raghavan, Biotech & Markets Analyst
A Groundbreaking Leap for Kidney Health In the battle against kidney diseases, we've just reached a significant milestone that promises to transform lives. The stage is set, the players are aligned, a
By Priya Raghavan, Biotech & Markets Analyst
Cystic fibrosis, a condition often whispered about but seldom fully understood, is like a relentless storm cloud overshadowing the lives it touches. This inherited disease paints a challenging picture
By Priya Raghavan, Biotech & Markets Analyst
Introduction As the dust from the COVID-19 pandemic begins to settle, one industry that continues to command strong levels of public trust and favourability is pharmaceuticals. According to the third
By Dr. Eleanor Vance, Regulatory Affairs Editor
In an era where scientific innovation consistently pushes the boundaries of what's possible, the Weizmann Institute has unveiled a groundbreaking research development: an entity that bears a striking
By Dr. Eleanor Vance, Regulatory Affairs Editor
In the ever-evolving field of healthcare, modern pharmaceutical advances play a crucial role in improving patient outcomes, enhancing treatment options, and revolutionizing the way we approach medicin
By Dr. Eleanor Vance, Regulatory Affairs Editor
A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored by pharmaceutical com
By Tom Okafor, Clinical Trials Correspondent
The medical field is a realm of constant discovery and improvement. Innovations and breakthroughs keep pushing the boundaries of our understanding, enabling us to better treat and prevent diseases. On
By Tom Okafor, Clinical Trials Correspondent
In the fast-paced world of pharmaceuticals, one North London pharmacy recently made waves with its remarkable transformation and rapid sale. The captivating story of this beautifully refitted establis
By James Whitfield, Manufacturing & Supply Chain Writer
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy